COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 267: Articles 2661-2670  | Next

Virological characteristics of the SARS-CoV-2 KP.2 variant
Kaku, Y., Uriu, K., Kosugi, Y., Okumura, K., Yamasoba, D., Uwamino, Y., Kuramochi, J., Sadamasu, K., Yoshimura, K., Nagashima, M., Asakura, H., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.04.24.590786 — Posted: 2024-04-26
A Qualitative Interview Study of General Practitioners' Experiences of Managing Post-COVID-19 Syndrome
Schulze, J., Lind, L., Rojas, A., Luedtke, L., Hensen, J., Bergelt, C., Haerter, M., Pohontsch, N. J.
10.1101/2024.04.23.24306074 — Posted: 2024-04-25
The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021-2022
Yang, J., Rai, K. K., Alfred, T., Massey, L., Massey, O., McGrath, L., Andersen, K. M., Tritton, T., Tsang, C., Butfield, R., Reynard, C., Mendes, D., Nguyen, J. L.
10.1101/2024.04.24.24306308 — Posted: 2024-04-25
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
Ruiz, F., Foreman, W., Lilly, M., Baharani, V. A., Depierreux, D. M., Chohan, V., Taylor, A. L., Guenthoer, J., Ralph, D., Matsen, F. A., Chu, H. Y., Bieniasz, P. D., Cote, M., Starr, T. N., Overbaugh, J.
10.1101/2024.04.24.590836 — Posted: 2024-04-25
An increase in aspartate aminotransferase levels can predict worsening disease severity in Japanese patients with COVID-19
Matsumoto, K., Nishida, T., Okabe, S., Sakamoto, N., Fujii, Y., Osugi, N., Sugimoto, A., Nakamatsu, D., Yamamoto, M., Fukui, K., Morimura, O., Abe, K., Okauchi, Y., Iwahashi, H., Inada, M.
10.1101/2024.04.23.24306214 — Posted: 2024-04-24
Development of a simple and highly sensitive virion concentration method to detect SARS-CoV-2 in saliva
Yamazaki, Y., Alonso, U., Galay, R. L., Yamazaki, W.
10.1101/2024.04.23.24306243 — Posted: 2024-04-24
Severe Maternal Morbidity Disparities Before and During the COVID Pandemic in a Medicaid Population
Meghea, C. I., Johnson, J. E., Roman, L. A., Bolder, H., Key, K. D., McCoy WHite, J., Yu, X.
10.1101/2024.04.24.24306226 — Posted: 2024-04-24
SARS-CoV-2 Omicron Envelope T9I adaptation confers resistance to autophagy
Klute, S., Nchioua, R., Cordsmeier, A., Vishwakarma, J., Koepke, L., Alshammary, H., Jung, C., Hirschenberger, M., Hoenigsperger, H., Fischer, J.-R., Zech, F., Stenger, S., Serra-Moreno, R., Gonzalez-Reiche, A. S., Sordillo, E. M., van Bakel, H., Simon, V., Kirchhoff, F., Jacob, T., Kmiec, D., Pichlmair, A., Ensser, A., Sparrer, K. M.
10.1101/2024.04.23.590789 — Posted: 2024-04-24
Bridging genomic gaps: A versatile SARS-CoV-2 benchmark dataset for adaptive laboratory workflows
Zufan, S. E., Judd, L. M., Walsh, C. J., Sait, M. L., Ballard, S. A., Kwong, J., Stinear, T. P., Seemann, T., Howden, B. P.
10.1101/2024.04.24.587375 — Posted: 2024-04-24
A unified theory for predicting pathogen mutual invasibility and co-circulation
Park, S. W., Cobey, S., Metcalf, J., Levine, J., Grenfell, B.
10.1101/2024.04.22.590623 — Posted: 2024-04-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).